Mark Sheptoff Financial Planning’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.8K Hold
480
0.02% 198
2025
Q4
$40.9K Hold
480
0.02% 208
2025
Q3
$37.3K Hold
480
0.02% 214
2025
Q2
$37.5K Hold
480
0.02% 206
2025
Q1
$34.8K Hold
480
0.02% 194
2024
Q4
$35.5K Hold
480
0.02% 201
2024
Q3
$31.7K Hold
480
0.02% 205
2024
Q2
$44.3K Hold
480
0.02% 185
2024
Q1
$45.9K Hold
480
0.03% 180
2023
Q4
$36.6K Hold
480
0.02% 184
2023
Q3
$33.3K Hold
480
0.02% 178
2023
Q2
$45.3K Hold
480
0.03% 167
2023
Q1
$39.7K Hold
480
0.02% 168
2022
Q4
$35.8K Hold
480
0.02% 166
2022
Q3
$40K Hold
480
0.02% 159
2022
Q2
$46K Hold
480
0.03% 165
2022
Q1
$57K Hold
480
0.03% 167
2021
Q4
$62K Hold
480
0.03% 167
2021
Q3
$54K Hold
480
0.03% 172
2021
Q2
$50K Hold
480
0.03% 185
2021
Q1
$40K Hold
480
0.02% 181
2020
Q4
$44K Buy
+480
New +$39.8K 0.03% 167
2020
Q3
Sell
-480
Closed -$33K 343
2020
Q2
$33K Hold
480
0.02% 170
2020
Q1
$30K Hold
480
0.02% 160
2019
Q4
$37K Hold
480
0.02% 169
2019
Q3
$35K Buy
+480
New +$33.7K 0.02% 171

Other funds holding EW

Mark Sheptoff Financial Planning's EW Position: Q1 2026 in Review

Mark Sheptoff Financial Planning held its Edwards Lifesciences (EW) position steady in Q1 2026 at 480 shares worth $39.8K. The position accounts for 0.02% of the portfolio, ranked #198.

Mark Sheptoff Financial Planning first reported a position in EW in Q3 2019 and has held it in 26 quarters since. The position peaked at $62K in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Mark Sheptoff Financial Planning held 480 shares of Edwards Lifesciences worth $39.8K as of Q1 2026.
  • Mark Sheptoff Financial Planning left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.02% of Mark Sheptoff Financial Planning's portfolio in Q1 2026, its #198 holding.
  • Mark Sheptoff Financial Planning first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 26 quarters since.
  • Mark Sheptoff Financial Planning's Edwards Lifesciences position peaked at $62K in Q4 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.